Skip to main content

Animations

MJFF Publications

6911 - 6920 of 8808 Results
Title
Year
  • Year
  • 2013
  • 1999
  • 2018
  • 2024
  • 2018
  • 2019
  • 2021
  • 2025
  • 2016
  • 2018
  • Summary Details
    RESTRICTED
    Title: The KV7.2/3 preferring channel opener ICA 27243 attenuates L-DOPA-induced dyskinesia in hemiparkinsonian rats
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2013.04.017
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Suppression of Pain Sensation Caused by Millimeter Waves
    Journal Name: Anesthesia & Analgesia
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1213/00000539-199904000-00029
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: Mendel and urate: Acid test or random noise?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.005
    Citation Count: 3
  • Summary Details
    OPEN
    Title: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01116-0
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Pink1 −/− Rats Show Early-Onset Swallowing Deficits and Correlative Brainstem Pathology
    Journal Name: Dysphagia
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00455-018-9896-5
    Citation Count: 42
  • Summary Details
    OPEN
    Title: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.038596
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines9050514
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Novel early‐onset Alzheimer‐associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathways
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70377
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028
    Citation Count: 60
  • Summary Details
    RESTRICTED
    Title: Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27492
    Citation Count: 162
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.